DHR
NYSEDanaher Corporation
Price
Key statistics
Insider activity
SEC EDGAR ↗Showing 20 recent filings. None are open-market buys/sells — recent activity is grants, option exercises, gifts or tax withholding (which don't signal conviction).
| Insider | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|
Bouda Christopher VP, Chief Accounting Officer | Tax withholding | 60 | $200.79 | $12,047.40 | 2026-07-15 |
FILLER LINDA Director | Option exercise | 3.3K | $71.88 | $237,060.24 | 2026-07-15 |
FILLER LINDA Director | Tax withholding | 1.18K | $200.79 | $237,132.99 | 2026-07-15 |
FILLER LINDA Director | Option exercise | 3.3K | $0.00 | — | 2026-07-15 |
Zerhouni Elias A. Director | Option exercise | 3.3K | $71.88 | $237,060.24 | 2026-07-15 |
Zerhouni Elias A. Director | Tax withholding | 1.18K | $200.79 | $237,132.99 | 2026-07-15 |
Zerhouni Elias A. Director | Option exercise | 3.3K | $0.00 | — | 2026-07-15 |
FILLER LINDA Director | Grant / award | 680 | $0.00 | — | 2026-05-15 |
FILLER LINDA Director | Grant / award | 1.7K | $0.00 | — | 2026-05-15 |
Couchara Georgeann SVP, Human Resources | Tax withholding | 281 | $161.91 | $45,496.71 | 2026-05-15 |
Stevens Raymond C Director | Grant / award | 680 | $0.00 | — | 2026-05-15 |
Stevens Raymond C Director | Grant / award | 1.7K | $0.00 | — | 2026-05-15 |
SPOON ALAN G Director | Grant / award | 680 | $0.00 | — | 2026-05-15 |
SPOON ALAN G Director | Grant / award | 1.7K | $0.00 | — | 2026-05-15 |
Sanders A Shane Director | Grant / award | 680 | $0.00 | — | 2026-05-15 |
Sanders A Shane Director | Grant / award | 1.7K | $0.00 | — | 2026-05-15 |
List Teri Director | Grant / award | 680 | $0.00 | — | 2026-05-15 |
List Teri Director | Grant / award | 1.7K | $0.00 | — | 2026-05-15 |
Zerhouni Elias A. Director | Grant / award | 680 | $0.00 | — | 2026-05-15 |
Zerhouni Elias A. Director | Grant / award | 1.7K | $0.00 | — | 2026-05-15 |
Source: SEC EDGAR Forms 4/4A (CIK 313616). Click an insider to open the original filing.
Social sentiment
Volume-weighted across live social sources
@Jeremymartin007 @simon58 @judgeyoung2 @jenbunn @ZY786 @EBE_day @ribbey @TraderRapp @tonyctl @zuby34 $MSFT was exception to atm rule there like one a week exception 😅 last week was $DHR remember
Fundamental analysis of $DHR (DANAHER CORP /DE/) based on financial data and reported results. #DHR #DANAHER
Imagine buying $DHR at its peak, only to watch it crash like this and then finding out there’s a way to get some money back. To all $DHR investors out there, we’ve got some important news: a $172.5 million investor settlement is now open for claims from shareholders who purchased shares between 2020 and 2023. The deadline is in two months, you can check if you’re eligible and claim your share: https://11th.com/cases/danaher-investor-settlement
$DHR building?
$CNSP $CDT $EDBL $DHR $TMO Bull Flag Price action. CNS-Pharmaceuticals CNSP is rebounding. Now get on the CNS Pharmaceuticals CNSP moon rocket 9700% on Monday open. FAST TRACK DESIGNATION + ORPHAN DRUG DESIGNATION + INTELLECTUAL PROPERTY COMMERCIALIZATION RIGHTS in E.U. & U.S.
$DHR Fingers crossed for a move above $195 in the morning!
$DHR in other words, if rainer knew how to lead an organization and orchestrate an earnings call like his counterpart at thermo fisher so much of the past two days, -10%+ worth and likely more to come, would not have been necessary. good grief.
@EBE_day @cubie @Jeremymartin007 @jenbunn @ZY786 @ribbey @TraderRapp @Tradermikes40 @tonyctl @zuby34 u have $DHR still ebe?
$DHR $195 target https://www.trade-ideas.com/share.php?code=ZO6iDT4RjzOH4JrSZ76YSVOVOt2X5PAy
$DHR The biotechnology segment has been a major growth driver, with bioprocessing equipment orders up more than 30% earlier this year, supported by pharmaceutical manufacturing demand!!
$DHR I sell yesterday My problem I can't wait 😶🌫️
$TMO $DHR $LMT $RTX $NOC cubie teaches price action. they knew
Latest news
Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
How Thermo Fisher Is Riding Bioproduction and AI-Led Growth Trends
Avantor Stock Surged Because One Segment Stopped Shrinking
Veralto’s (NYSE:VLTO) Q2 CY2026 Non-GAAP EPS Beat Estimates
[Latest] Global Precision Diagnostics And Medicine Market Size/Share Worth USD 345.75 Billion by 2035 at a 8.91% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
Danaher (DHR) Could Be 16% Undervalued On Earnings And 2026 Revenue Guidance
Danaher (DHR) Stock Tries To Steady After A Sharp Post Earnings Selloff
Here's Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
Edwards' Q2 Earnings & Revenues Top Estimates, Stock Rises
6 Medical-Device Stocks to Buy After a Massive Selloff
Get insider-buy alerts
Free weekly digest of the most notable SEC insider purchases — plus early access to real-time alerts on your watchlist.